Valuation: Progyny, Inc.

Capitalization 1.8B 1.56B 1.46B 1.33B 2.45B 155B 2.78B 17.09B 6.66B 71.04B 6.76B 6.62B 260B P/E ratio 2025 *
39x
P/E ratio 2026 * 24.8x
Enterprise value 1.52B 1.32B 1.23B 1.12B 2.07B 131B 2.35B 14.43B 5.62B 59.96B 5.71B 5.59B 219B EV / Sales 2025 *
1.24x
EV / Sales 2026 * 0.99x
Free-Float
76.13%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.41%
1 week-3.00%
Current month-2.19%
1 month-3.80%
3 months+3.29%
6 months+43.94%
Current year+21.91%
More quotes
1 week 20.84
Extreme 20.845
22.69
1 month 20.25
Extreme 20.25
22.93
Current year 17.01
Extreme 17.0076
26.76
1 year 13.39
Extreme 13.39
30.42
3 years 13.39
Extreme 13.39
46.5
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 31/12/2021
President 48 31/12/2021
Director of Finance/CFO 59 14/09/2020
Director TitleAgeSince
Chairman 65 31/12/2021
Director/Board Member 50 15/12/2016
Director/Board Member 58 31/12/2021
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-2.41%-3.00%-22.05%-21.71% 1.8B
-1.56%+3.40%-36.93%-32.10% 284B
-0.43%-2.24%-28.10%-16.47% 86.88B
+0.64%+1.67%-4.77%+29.18% 84.79B
+0.13%+1.98%-34.46%-44.50% 28.39B
-0.29%+0.11%-19.89%-27.56% 27.48B
+1.59%+0.42%-2.90%+13.93% 16.16B
-0.93%-1.84%+79.57%+32.68% 2.96B
-1.54%-5.56%+164.68%+37.38% 1.47B
-1.16%-0.85%-11.42% - 402M
Average -0.60%-0.32%+8.37%-3.24% 53.48B
Weighted average by Cap. -0.78%+2.30%-27.09%-18.29%
See all sector performances

Financials

2025 *2026 *
Net sales 1.22B 1.06B 992M 902M 1.66B 105B 1.89B 11.61B 4.52B 48.26B 4.59B 4.5B 176B 1.37B 1.18B 1.11B 1.01B 1.86B 118B 2.11B 12.95B 5.05B 53.84B 5.12B 5.02B 197B
Net income 49.11M 42.54M 39.79M 36.19M 66.71M 4.23B 75.71M 466M 181M 1.94B 184M 180M 7.07B 76.14M 65.96M 61.7M 56.11M 103M 6.55B 117M 722M 281M 3B 286M 280M 10.97B
Net Debt -281M -244M -228M -207M -382M -24.2B -433M -2.67B -1.04B -11.08B -1.05B -1.03B -40.5B -450M -389M -364M -331M -611M -38.7B -693M -4.26B -1.66B -17.72B -1.69B -1.65B -64.77B
More financial data * Estimated data
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
678
More about the company
Date Price Change Volume
13/06/25 21.03 $ -2.41% 819,289
12/06/25 21.55 $ -0.65% 735,226
11/06/25 21.69 $ -3.30% 969,360
10/06/25 22.43 $ +2.09% 816,201
09/06/25 21.97 $ +1.34% 822,898

Delayed Quote Nasdaq, June 13, 2025 at 09:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
21.03USD
Average target price
26.25USD
Spread / Average Target
+24.82%
Consensus

Quarterly revenue - Rate of surprise